Toggle menu

TPTIH

Start date:
August 2015
End date:
Predicted September 2017
Co-ordinated by:
The University of Nottingham

To establish genetic associations between patients with thiazide-induced hyponatraemia and patients taking a thiazide who did not develop hyponatraemia.

Eligibility criteria

Inclusion criteria:

  • Age 18-100 years
  • Have the capacity to give informed consent
  • Be taking a thiazide or thiazide-related diuretic unless in the non-thiazide control group
  • Plasma sodium concentration of less than 130 mM for cases and between 135 mM and 145 mM for controls

Local PI

Dr Ann Lockman

Consultant in Acute Medicine

Research Team

Julia Grahamslaw

Lead Research Nurse

Caroline Blackstock

AMU Senior Research Nurse

Bev Goldberg

AMU Senior Research Nurse

Rachel O'Brien

Lead Research Nurse

More EMERGE Trials

Developing a molecular tool to stratify the acute joint presentation: facilitating early diagnosis of septic arthritis (Septic Arthritis Biomarker Emergency Rule-out - SABER)

Read more

SABER

Developing a molecular tool to stratify the acute joint presentation: facilitating early diagnosis of septic arthritis (Septic Arthritis Biomarker Emergency Rule-out - SABER)

This is a study looking at incidence and risk factors for poor ankle functional recovery, and the development and progression of post-traumatic ankle osteoarthritis after significant ankle ligament injury.

Read more

SALI Study

SALI study - Significant Ankle Ligament Injury

DASH

DASH is a randomised clinical trial investigating a treatment to reverse the effects of blood-thinning medications.